Clinical Trial Update: Aliskiren and Muscle Sympathetic Nerve Activity [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating aliskiren's effect on muscle sympathetic nerve activity in individuals with chronic kidney disease and hypertension.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Hypertension

Drugs mentioned

• Aliskiren (Aliskiren)

Snippet

Sponsor: UMC Utrecht | Conditions: Chronic Kidney Disease, Hypertension | Phase 4 | Status: UNKNOWN